Technical Field
The present invention relates to medical therapy systems in general, including therapeutic cooling, heating, and compression systems used in association therewith, and more particularly, but not by way of limitation, to a programmable, thermal therapy and external pneumatic compression for the prevention of deep vein thrombosis.
Description of the Related Art
Considerable medical attention has been given to the serious medical issue of Deep Vein Thrombosis (“DVT”). One approach to the prevention of DVT has been External Pneumatic Compressions (“EPC”). EPC has been shown to be helpful as a prophylaxis for DVT, although refinements over existing systems are still in need. For example, multiple articles have been written addressing this issue, including a compilation of recommendations for preventing DVT (Heit J A: Current Recommendations for Prevention of Deep Venous Thrombosis. In: Handbook of Venous Disorders. Gloviczki P, Yao J S, eds. Cambridge, The University Press, 1996). Engineering studies are presented which also address EPC as a preventative for DVT (Kamm R D: Bioengineering Studies of Periodic External Compression as Prophylaxis Against Deep Vein Thrombosis—Part 1: Numerical Studies. J Biomech Engineering 104(1): 87-95, 1982). Such efforts are meritorious for patient health due to possible Pulmonary Embolism (“PE”) resulting from DVT (National Institutes of Health Consensus Development Conference Statement: Prevention of Venous Thrombosis and Pulmonary Embolism. JAMA 6(2) 744-749, 1986). Additionally, studies have been performed relative to DVT and orthopedic surgery (“OS”) (Westrich G H, Sculco T P: Prophylaxis Against Deep Vein Thrombosis After Total Knee Arthroplasty. J Bone Joint Surg 78-A(6): 826-834, 1996).
Relative to OS, physicians have long recognized the need to provide warmth and cooling directly to patients as part of OS therapy. Better recoveries have been reported, for example, using cold therapy for orthopedic patients. The benefits of warming patients undergoing surgery has also been demonstrated. It may also be desirable to cool portions of a patient's anatomy in certain circumstances. Yet another advantageous therapy is the application of heat then cold to certain injured areas. See, for example, U.S. Pat. No. 5,989,285 (the '285 patent) assigned to Thermotek, Inc. and incorporated herein by reference.
Several devices have been developed that deliver temperature-controlled fluids through pads or convective thermal blankets to achieve the above thermal purpose. Typically these devices have a heating or a cooling element, a source for the fluid, a pump for forcing the fluid through the pad or blanket, and a thermal interface between the patient and the temperature-controlled fluid. U.S. Pat. No. 4,884,304 to Elkins is directed to a mattress-cover device that contains liquid flow channels that provide the selective heating or cooling by conduction.
Devices have also been developed for providing heat to a person in bed. Electric blankets containing electric heating elements have been used for years to warm a person in bed. Cooling blankets, such as the blanket disclosed in U.S. Pat. No. 4,660,388 to Greene, have also been proposed. Greene discloses a cooling cover having an inflatable pad with plenum chambers at opposite ends thereof. Cool air is generated in a separate unit and directed to the pad and out a number of apertures on the underside of the pad and against the body of the person using the cover.
A disposable heating or cooling blanket that has three layers of flexible sheeting is disclosed in U.S. Pat. No. 5,125,238 to Ragan, et al. Two of the layers form an air chamber and the third includes a comfortable layer for contact with the patient. Conditioned air is directed toward the covered person through a multiplicity of orifices in the bottom layers of the blanket.
The temperature-controlled blanket and bedding assembly disclosed in the '285 patent includes a temperature-controlled blanket and temperature-controlled bedding system that provide both recirculating temperature-controlled fluid and temperature-controlled gas to enhance performance for convectively heating or cooling a patient. Counter-flow or co-flow heat-exchanging principles between the temperature-controlled liquid and the temperature-controlled gas achieve temperature uniformity across different sections of the blanket and the bedding system. Drapes and the temperature-controlled bedding system provide a temperature-controlled envelope around a person using the bedding system. In one embodiment of the bedding system, an air portion of the bedding system is provided that supplies a fluid portion of the overall bedding system. In another embodiment of the bedding system, the fluid portion of the bedding system is provided for use with a patient bed that supplies the air portion of the overall bedding system.
U.S. Pat. No. 5,097,829 to Quisenberry describes an improved temperature-controlled fluid-circulating system for automatically cooling a temperature-controlled fluid in a thermal blanket with a thermoelectric-cooling device having a cold side and a hot side when powered by electricity. The temperature-controlled fluid is cooled by a cold side of the cooling device and is pumped through, to, and from the blanket through first and second conduits.
The present invention relates to thermal therapy and DVT compression system for use in heating or cooling a patient. In one aspect of the invention, a DVT therapy system includes at least a control unit adapted, a thermal-treatment blanket, a compressive-therapy treatment device, a first set of connector tubes, and a second set of connector tubes. The control unit is adapted to heat and cool a heat-transfer liquid within about 37-105° F. and to provide compressed air at a pressure of at least 25 mmHg above ambient atmospheric pressure. The thermal-treatment blanket is adapted for receipt of the transfer liquid from the control unit and to send the heat-transfer liquid back to the control unit, a compressive-therapy treatment device adapted to utilize the compressed air from the control unit, and a first and second set of connector tubes. The first set of connector tubes is adapted to facilitate the flow of the heat-transfer liquid between the control unit and the thermal treatment blanket. The second set of connector tubes is adapted to facilitate the flow of the compressed air between the control unit and the compressive treatment device.
In another aspect, a DVT method includes providing a control unit adapted to heat and cool a heat-transfer liquid to a temperature within the range of about 37-105° F. and adapted to provide compressed air at a pressure of at least 25 mmHg above ambient atmospheric pressure, providing a thermal treatment blanket adapted for receipt of the heat-transfer liquid from the control unit and for sending the heat-transfer liquid back to the control unit, and applying a hot or cold treatment to an individual's skin area. The method also includes providing a compressive-therapy treatment device utilizing the compressed air from the control unit and applying a compressive treatment to an individual's skin area. The method further includes providing a first set of connector tubes adapted to connect the control unit and the thermal treatment blanket to facilitate the flow of the heat-transfer liquid therebetween, and providing a second set of connector tubes adapted to connect the control unit and the compressive treatment device to facilitate the flow of the compressed air therebetween.
In a further aspect of the invention, a DVT therapy treatment device includes an upper and lower sheet of biocompatible material, a first air-tight, inflatable portion, a second air-tight inflatable portion, a first hook-and-loop fastener, a second-hook-and-loop fastener, and an inlet. The upper and lower sheet sheets have substantially the same shape and are sealed on an outer edge thereof. The first air-tight inflatable portion includes an elongated strap formed from both the upper and lower sheets, with the elongated strap being adapted to wrap around an individual's ankle. The second air-tight inflatable portion is attached to the first portion, has two longer sides that are relatively pinched at a location generally in the middle of the longer sides and two shorter sides, and is formed from the upper and lower sheets. The first hook-and-loop fastener is on a distal end on the first portion at a location away from the second portion. The second hook-and-loop fastener is disposed on a left edge of the second portion and is adapted to mate with the first hook-and-loop fastener to secure the DVT therapy device to the individual's foot for subsequent compressive therapy.
In yet another aspect of the invention, a DVT therapy device includes a first and second sheet of biocompatible material of a generally trapezoidal shape having concentric arcuate top and bottom edges, the first and second sheet being sealed on an outer edge thereof to create an air-tight inflatable structure, a first and second weld located symmetrically about the center of the first and second sheet, a third and fourth weld extending from the first and second welds respectively to create an ‘S’ shaped portion disposed in the center of the first and second welds, and an inlet for receipt of compressed air from the control unit, the inlet allowing the compressed air to inflate the ‘S’ shaped portion to facilitate compressive treatment of the individual's calf.
A more complete understanding of the method and apparatus of the present invention may be obtained by reference to the following Detailed Description when taken in conjunction with the accompanying Drawings wherein:
Applicants have discovered that the use of both thermal therapy and compression therapy during and for post-surgical treatment for the prevention of DVT is advantageous. As referenced above, numerous articles have been written on the problems associated with DVT and the utilization of thermal therapy is already well known. Consistent therewith, methods of and apparatuses for providing pressurized and thermally controlled fluids for use with patients in need of such therapy are disclosed. A versatile control unit is adapted for providing one of a plurality of treatment modalities. As described below, in one modality, a thermally controlled liquid is produced and provided in a configuration facilitating flow through a treatment pad or blanket for thermal therapy. In a second embodiment, air compression is provided such that a blanket can receive a flow of pressurized air to cause a degree of compression relative to the patient. In a third embodiment, DVT system modules are provided so that the prevention of DVT can be afforded. In a fourth embodiment, thermal therapy is provided with DVT treatment.
As further described below, a control unit will be shown to be provided with (a) thermally controlled fluid, (b) thermally controlled fluid and compression air, and (c) thermally controlled fluid, compression air, and DVT systems. The control unit for providing these selective features is described within a single chassis design capable of providing any of the modalities therein or herein described. This selective versatility provides financial and manufacturing incentives in that the simple design selectively can provide an industrial, medical, or electro-optic version that produces only thermally controlled liquid, such as co-liquid for cooling industrial equipment, in a configuration adaptable for other applications. Therefore, in one embodiment of the invention, the production of a control unit adapted only for chilling electronic components is conceivable while the same chassis and initial components place therein may also be adaptable for a version that provides a prophylaxis for DVT.
Referring first to
Referring still to
Referring now to
Still referring to
Referring specifically now to a dual-fan arrangement, fans are positioned to suck air from around the filtered grated region disposed peripherally about the electronic components so that the air flow is both quiet and at a rate allowing initial electronic cooling and then being available to be pushed into the top section of the control unit 4 where most heat dissipation is needed. In essence, the control unit 4 facilitates pulling air through the lower power supply that could then be forced upwardly for maximum cooling where maximum thermal change is needed.
Referring still to
Referring now to
Referring now to
Referring now to
Relative to the DVT pulsing, various embodiments of the present invention provide for a broad pulse configuration. It has been reported that a narrow pulse generated by opening a solenoid on compressed air may be hazardous due to the intensity of the pulse damaging cells. A broader pulse as described herein will apparently not cause the same degree of harm and may reduce harm while maintaining the same degree of efficiency in the DVT prevention. The other solenoids shown herein permit choosing between the right or left routing of the compression stroke as further defined in other figures.
Referring back to
Table 1 illustrates information regarding an embodiment of the invention relative to various existing products on the market for addressing calf and foot DVT concerns. All pressure references in Table 1 pertain to mmHg above the ambient atmospheric pressure. It will be seen from Table 1 that currently available literature indicates an inflation time of 3-20 seconds for a calf and around 0.3 seconds for a foot. Such inflation times are different than those typically used by the Applicants and Applicants' assignee “ThermoTek” as referenced in Table 1 wherein the inflation time for one embodiment of the system of the present invention is on the order of 8 seconds for a calf in an alternating mode. Likewise, relative to the foot, which is often specifically of concern, an inflation time on the order of 9 seconds as compared to existing literature and existing information regarding a commercially available product in the range of 0.3 seconds. This differential is, as referenced above, a much more gradual pulse rate and is currently understood by Applicants to create less cell damage for DVT treatment. The information presented above includes preferred ranges while other times are contemplated by the Applicants to be capable of achieving the desired results.
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
The control unit 4 and the blanket 8 may be adapted for the administration of hot, cold, and/or compression therapies to a body portion of the patient. For example, the blanket 8 may cover different areas of the human body. Current thermal design requirements for temperature therapy in various embodiments of the present invention are as follows: 1) the system must be able to heat the fluid from around 49° F. to around 105° F. with the largest blanket attached to a typical man (e.g., 5′10″ and 180 lbs.) at an ambient of 77° F. within 10 minutes; 2) the system must be able to cool the fluid from 105° F. to 49° F. with the largest blanket attached to the typical man at an ambient of 77° F. within 20 minutes; and 3) the system must cool the fluid to 37° F. at an ambient of 77° F. within 90 minutes. These requirements should be with a minimum compression of 25 mm Hg. The connector 10 provides a fluid and/or gas connection between the control unit 4 and the blanket 8 for the transfer of gas and heat transfer fluid. The connector 10 may also allow for transfer of electrical sensor signals and/or data signals between the blanket 8 and the control unit 4. The emergency relief valve 9 is utilized to quickly decompress the blanket 8 if needed.
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Various of the above-described Figures illustrate the mounting of dual-fan assemblies for impinging style airflow. In this manner, the air is brought in at the base of the heat sink and driven in or impinged against the heat sink, which serves to lower the pressure drop and increase air flow for a given heat sink. A single heat sink may be used. Such a configuration of air flow with an enlarged grate configuration may be used to afford noise abatement.
In one embodiment, the size of the reservoir has been reduced relative to a number of earlier models of thermo-electric (TEC) systems such that only around 175 watts are utilized compared to 205 for typical earlier systems. As such, the control unit 4 is configurable with TEC assemblies maximizing efficiency. With such an assembly, multiple applications of industrial with non-air compression and/or medical with air compression and/or DVT is afforded in a single chassis 81. With regard to the medical modality, thermal therapy may be afforded to a patient to reduce swelling and edema while, in conjunction with the DVT prophylaxis, preventing blood from pooling in lower body extremities. This is particularly important after surgery when anesthesia has been involved. It is well known that anesthetics often tend to reduce the wall strength of veins and, if not otherwise treated, appropriate venous pumping may not be afforded allowing for blood pooling in clots. With the DVT application as disclosed herein, both thermal and DVT prophylaxis with a low-noise configuration may be achieved.
Still referring to
For purposes of this patent application, the following definitions are to be used:
Referring now to
The previous description is of embodiments of the invention. The scope of the invention should not necessarily be limited by this description. The scope of the present invention is instead defined by the following claims.
The present application is a continuation of U.S. patent application Ser. No. 11/733,709, filed Apr. 10, 2007, now U.S. Pat. No. 9,119,705. U.S. patent application Ser. No. 11/733,709 claims priority from, and incorporates by reference for any purpose the entire disclosure of each of U.S. Provisional Patent Application Ser. No. 60/791,132 filed Apr. 11, 2006 and U.S. Provisional Patent Application Ser. No. 60/817,932 filed Jun. 30, 2006. This application hereby incorporates by reference commonly assigned U.S. Pat. Nos. 5,097,829, 5,989,285, and U.S. Patent Application Serial Nos. 60/488,709 filed Jul. 18, 2003, 60/550,658 filed Mar. 5, 2004, 60/558,453 filed Jul. 16, 2004, Ser. No. 09/328,183 filed Jun. 8, 1998, and Ser. No. 10/894,369 filed Jul. 19, 2004. U.S. patent application Ser. No. 11/733,709 and U.S. Provisional Patent Application Nos. 60/791,132 and 60/817,932 are each incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
773828 | Titus | Nov 1904 | A |
2110022 | Kliesrath | Mar 1938 | A |
2504308 | Donkle, Jr. | Apr 1950 | A |
3014117 | Madding | Dec 1961 | A |
3164152 | Vere Nicoll | Jan 1965 | A |
3179106 | Meredith | Apr 1965 | A |
3345641 | Jennings | Oct 1967 | A |
3367319 | Carter, Jr. | Feb 1968 | A |
3548809 | Conti | Dec 1970 | A |
3608091 | Olson et al. | Sep 1971 | A |
3660849 | Jonnes et al. | May 1972 | A |
3736764 | Chambers et al. | Jun 1973 | A |
3738702 | Jacobs | Jun 1973 | A |
3744053 | Parker et al. | Jul 1973 | A |
3744555 | Fletcher et al. | Jul 1973 | A |
3862629 | Rotta | Jan 1975 | A |
3894213 | Agarwala | Jul 1975 | A |
4006604 | Seff | Feb 1977 | A |
4013069 | Hasty | Mar 1977 | A |
4029087 | Dye et al. | Jun 1977 | A |
4206751 | Schneider | Jun 1980 | A |
4224941 | Stivala | Sep 1980 | A |
4375217 | Arkans | Mar 1983 | A |
4402312 | Villari et al. | Sep 1983 | A |
4419988 | Mummert | Dec 1983 | A |
4459468 | Bailey | Jul 1984 | A |
4459822 | Pasternack | Jul 1984 | A |
4471787 | Bentall | Sep 1984 | A |
4503484 | Moxon | Mar 1985 | A |
4523594 | Kuznetz | Jun 1985 | A |
4547906 | Nishida et al. | Oct 1985 | A |
4590925 | Dillon | May 1986 | A |
4597384 | Whitney | Jul 1986 | A |
4608041 | Nielsen | Aug 1986 | A |
D285821 | Kneisley | Sep 1986 | S |
D288372 | Adams | Feb 1987 | S |
4660388 | Greene, Jr. | Apr 1987 | A |
4738249 | Linman et al. | Apr 1988 | A |
D295897 | Thimm-Kelly | May 1988 | S |
4741338 | Miyamae | May 1988 | A |
4795435 | Steer | Jan 1989 | A |
4821354 | Little | Apr 1989 | A |
4844072 | French et al. | Jul 1989 | A |
4884304 | Elkins | Dec 1989 | A |
4901200 | Mazura | Feb 1990 | A |
4911231 | Horne et al. | Mar 1990 | A |
4926881 | Ichinomiya et al. | May 1990 | A |
4962761 | Golden | Oct 1990 | A |
4979375 | Nathans et al. | Oct 1990 | A |
4969881 | Viesturs | Nov 1990 | A |
4989589 | Pekanmaki et al. | Feb 1991 | A |
4995698 | Myers | Feb 1991 | A |
4996970 | Legare | Mar 1991 | A |
5044364 | Crowther | Sep 1991 | A |
5051562 | Bailey et al. | Sep 1991 | A |
D320872 | McCrane | Oct 1991 | S |
5062414 | Grim | Nov 1991 | A |
5067040 | Fallik | Nov 1991 | A |
5080089 | Mason et al. | Jan 1992 | A |
5090409 | Genis | Feb 1992 | A |
5092271 | Kleinsasser | Mar 1992 | A |
5097829 | Quisenberry | Mar 1992 | A |
5106373 | Augustine et al. | Apr 1992 | A |
5112045 | Mason et al. | May 1992 | A |
5117812 | McWhorter | Jun 1992 | A |
5125238 | Ragan et al. | Jun 1992 | A |
5165127 | Nicholson | Nov 1992 | A |
5179941 | Siemssen et al. | Jan 1993 | A |
5184612 | Augustine | Feb 1993 | A |
5186698 | Mason et al. | Feb 1993 | A |
5230335 | Johnson, Jr. et al. | Jul 1993 | A |
5232020 | Mason et al. | Aug 1993 | A |
5241951 | Mason et al. | Sep 1993 | A |
5243706 | Frim et al. | Sep 1993 | A |
5261399 | Klatz et al. | Nov 1993 | A |
5263538 | Amidieu et al. | Nov 1993 | A |
5285347 | Fox et al. | Feb 1994 | A |
D345082 | Wenzl | Mar 1994 | S |
D345609 | Mason et al. | Mar 1994 | S |
D345802 | Mason et al. | Apr 1994 | S |
D345803 | Mason et al. | Apr 1994 | S |
5300101 | Augustine et al. | Apr 1994 | A |
5300102 | Augustine et al. | Apr 1994 | A |
5300103 | Stempel et al. | Apr 1994 | A |
5303716 | Mason et al. | Apr 1994 | A |
5315994 | Guibert et al. | May 1994 | A |
5316250 | Mason et al. | May 1994 | A |
D348106 | Mason et al. | Jun 1994 | S |
5323847 | Koizumi et al. | Jun 1994 | A |
5324319 | Mason et al. | Jun 1994 | A |
5324320 | Augustine et al. | Jun 1994 | A |
D348518 | Mason et al. | Jul 1994 | S |
5330519 | Mason et al. | Jul 1994 | A |
5336250 | Augustine | Aug 1994 | A |
5342411 | Maxted et al. | Aug 1994 | A |
5343579 | Dickerhoff et al. | Sep 1994 | A |
5350417 | Augustine | Sep 1994 | A |
D351472 | Mason et al. | Oct 1994 | S |
5352174 | Mason et al. | Oct 1994 | A |
5354117 | Danielson et al. | Oct 1994 | A |
D352781 | Mason et al. | Nov 1994 | S |
5360439 | Dickerhoff et al. | Nov 1994 | A |
5370178 | Agonafer et al. | Dec 1994 | A |
5371665 | Quisenberry et al. | Dec 1994 | A |
D354138 | Kelly | Jan 1995 | S |
D357747 | Kelly | Apr 1995 | S |
5402542 | Viard | Apr 1995 | A |
5405370 | Irani | Apr 1995 | A |
5405371 | Augustine et al. | Apr 1995 | A |
5407421 | Goldsmith | Apr 1995 | A |
D358216 | Dye | May 1995 | S |
5411494 | Rodriguez | May 1995 | A |
5411541 | Bell et al. | May 1995 | A |
5417720 | Mason | May 1995 | A |
5440450 | Lau et al. | Aug 1995 | A |
5449379 | Hadtke | Sep 1995 | A |
5466250 | Johnson, Jr. et al. | Nov 1995 | A |
5496262 | Johnson, Jr. et al. | Mar 1996 | A |
5496357 | Jensen et al. | Mar 1996 | A |
5505726 | Meserol | Apr 1996 | A |
5507792 | Mason | Apr 1996 | A |
5509894 | Mason et al. | Apr 1996 | A |
5514079 | Dillon | May 1996 | A |
5528485 | Devilbiss et al. | Jun 1996 | A |
5561981 | Quisenberry et al. | Oct 1996 | A |
5566062 | Quisenberry et al. | Oct 1996 | A |
D376013 | Sandman et al. | Nov 1996 | S |
5578022 | Scherson et al. | Nov 1996 | A |
5584798 | Fox | Dec 1996 | A |
5588954 | Ribando et al. | Dec 1996 | A |
5591200 | Cone et al. | Jan 1997 | A |
5603728 | Pachys | Feb 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
D380874 | Caswell | Jul 1997 | S |
5645081 | Argenta et al. | Jul 1997 | A |
5648716 | Devilbiss et al. | Jul 1997 | A |
D383546 | Amis et al. | Sep 1997 | S |
D383547 | Mason et al. | Sep 1997 | S |
D383848 | Mason et al. | Sep 1997 | S |
5662695 | Mason et al. | Sep 1997 | A |
5669872 | Fox | Sep 1997 | A |
5672152 | Mason et al. | Sep 1997 | A |
5675473 | McDunn et al. | Oct 1997 | A |
5682748 | DeVilbiss et al. | Nov 1997 | A |
5689957 | DeVilbiss et al. | Nov 1997 | A |
5690849 | DeVilbiss et al. | Nov 1997 | A |
5711029 | Visco et al. | Jan 1998 | A |
5711155 | DeVilbiss et al. | Jan 1998 | A |
D393073 | Downing et al. | Mar 1998 | S |
5731954 | Cheon | Mar 1998 | A |
5733321 | Brink | Mar 1998 | A |
D394707 | Tsubooka | May 1998 | S |
5755755 | Panyard | May 1998 | A |
5772618 | Mason et al. | Jun 1998 | A |
5782780 | Mason et al. | Jul 1998 | A |
5795312 | Dye | Aug 1998 | A |
5807294 | Cawley et al. | Sep 1998 | A |
5827208 | Mason | Oct 1998 | A |
5831824 | McDunn et al. | Nov 1998 | A |
D403779 | Davis et al. | Jan 1999 | S |
D404490 | Tripolsky | Jan 1999 | S |
D405884 | Roper | Feb 1999 | S |
5865841 | Kolen et al. | Feb 1999 | A |
5871526 | Gibbs et al. | Feb 1999 | A |
5890371 | Rajasubramanian et al. | Apr 1999 | A |
5897581 | Fronda et al. | Apr 1999 | A |
5901037 | Hamilton et al. | May 1999 | A |
5913885 | Klatz et al. | Jun 1999 | A |
5923533 | Olson | Jul 1999 | A |
5947914 | Augustine | Sep 1999 | A |
5950234 | Leong et al. | Sep 1999 | A |
5980561 | Kolen et al. | Nov 1999 | A |
5989285 | DeVilbiss et al. | Nov 1999 | A |
6007559 | Arkans | Dec 1999 | A |
6030412 | Klatz et al. | Feb 2000 | A |
6055157 | Bartilson | Apr 2000 | A |
6058010 | Schmidt et al. | May 2000 | A |
6058712 | Rajasubramanian et al. | May 2000 | A |
6080120 | Sandman et al. | Jun 2000 | A |
D428153 | Davis | Jul 2000 | S |
D430288 | Mason et al. | Aug 2000 | S |
D430289 | Mason et al. | Aug 2000 | S |
6117164 | Gildersleeve et al. | Sep 2000 | A |
6125036 | Kang et al. | Sep 2000 | A |
6129688 | Arkans | Oct 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
6156059 | Olofsson | Dec 2000 | A |
6176869 | Mason et al. | Jan 2001 | B1 |
6178562 | Elkins | Jan 2001 | B1 |
6186977 | Andrews et al. | Feb 2001 | B1 |
6231532 | Watson et al. | May 2001 | B1 |
6235049 | Nazerian | May 2001 | B1 |
6238427 | Matta | May 2001 | B1 |
6260890 | Mason | Jul 2001 | B1 |
6270481 | Mason et al. | Aug 2001 | B1 |
6277143 | Klatz et al. | Aug 2001 | B1 |
6295819 | Mathiprakasam et al. | Oct 2001 | B1 |
6305180 | Miller et al. | Oct 2001 | B1 |
6312453 | Stefanile et al. | Nov 2001 | B1 |
6319114 | Nair et al. | Nov 2001 | B1 |
6352550 | Gildersleeve et al. | Mar 2002 | B1 |
6358219 | Arkans | Mar 2002 | B1 |
6368592 | Colton et al. | Apr 2002 | B1 |
6436064 | Kloecker | Aug 2002 | B1 |
6443978 | Zharov | Sep 2002 | B1 |
6462949 | Parish, IV et al. | Oct 2002 | B1 |
6463336 | Mawhinney | Oct 2002 | B1 |
6468237 | Lina | Oct 2002 | B1 |
6508831 | Kushnir | Jan 2003 | B1 |
D472322 | Hoglund et al. | Mar 2003 | S |
D473315 | Miros et al. | Apr 2003 | S |
D473656 | Miros et al. | Apr 2003 | S |
D473948 | Elkins et al. | Apr 2003 | S |
6551264 | Cawley et al. | Apr 2003 | B1 |
6551347 | Elkins | Apr 2003 | B1 |
D474544 | Hoglund et al. | May 2003 | S |
6562060 | Momtaheni | May 2003 | B1 |
6592535 | Ravikumar | Jul 2003 | B2 |
6596016 | Vreman | Jul 2003 | B1 |
6648904 | Altshuler et al. | Nov 2003 | B2 |
D484601 | Griffiths et al. | Dec 2003 | S |
D484602 | Griffiths et al. | Dec 2003 | S |
6660027 | Gruszecki et al. | Dec 2003 | B2 |
6667883 | Solis et al. | Dec 2003 | B1 |
6675072 | Kerem | Jan 2004 | B1 |
D486870 | Mason | Feb 2004 | S |
6695823 | Lina et al. | Feb 2004 | B1 |
6719713 | Mason | Apr 2004 | B2 |
6719728 | Mason et al. | Apr 2004 | B2 |
6736787 | McEwen et al. | May 2004 | B1 |
D492411 | Bierman | Jun 2004 | S |
6775137 | Chu et al. | Aug 2004 | B2 |
D496108 | Machin et al. | Sep 2004 | S |
6786879 | Bolam | Sep 2004 | B1 |
6789024 | Kochan, Jr. et al. | Sep 2004 | B1 |
6802823 | Mason | Oct 2004 | B2 |
D499846 | Cesko | Dec 2004 | S |
6834712 | Parish et al. | Dec 2004 | B2 |
6846295 | Ben-Nun | Jan 2005 | B1 |
6848498 | Seki et al. | Feb 2005 | B2 |
6855158 | Stolpmann | Feb 2005 | B2 |
6893414 | Goble et al. | May 2005 | B2 |
D506553 | Tesluk | Jun 2005 | S |
6935409 | Parish, IV et al. | Aug 2005 | B1 |
6936019 | Mason | Aug 2005 | B2 |
D510140 | Brown | Sep 2005 | S |
6945988 | Jones | Sep 2005 | B1 |
D510626 | Krahner et al. | Oct 2005 | S |
6986783 | Gunn et al. | Jan 2006 | B2 |
D515218 | McGuire et al. | Feb 2006 | S |
7004915 | Boynton et al. | Feb 2006 | B2 |
D523147 | Tesluk | Jun 2006 | S |
7066949 | Gammons et al. | Jun 2006 | B2 |
7081128 | Hart et al. | Jul 2006 | B2 |
D533668 | Brown | Dec 2006 | S |
7195624 | Lockwood et al. | Mar 2007 | B2 |
7198046 | Argenta et al. | Apr 2007 | B1 |
7216651 | Argenta et al. | May 2007 | B2 |
D551351 | Silva | Sep 2007 | S |
D551352 | Frangi | Sep 2007 | S |
7306568 | Diana | Dec 2007 | B2 |
7354411 | Perry et al. | Apr 2008 | B2 |
D568482 | Gramza et al. | May 2008 | S |
D569985 | Ganapathy et al. | May 2008 | S |
7427153 | Jacobs et al. | Sep 2008 | B1 |
7429252 | Sarangapani | Sep 2008 | B2 |
7484552 | Pfahnl | Feb 2009 | B2 |
7492252 | Maruyama | Feb 2009 | B2 |
7524286 | Johnson | Apr 2009 | B2 |
7532953 | Vogel | May 2009 | B2 |
7553306 | Hunt et al. | Jun 2009 | B1 |
D595620 | Kingsbury | Jul 2009 | S |
D601707 | Chouiller | Oct 2009 | S |
7608066 | Vogel | Oct 2009 | B2 |
7618382 | Vogel et al. | Nov 2009 | B2 |
D608006 | Avitable et al. | Jan 2010 | S |
D612947 | Turtzo et al. | Mar 2010 | S |
D613870 | Shust | Apr 2010 | S |
7717869 | Eischen, Sr. | May 2010 | B2 |
D618358 | Avitable et al. | Jun 2010 | S |
D619267 | Beckwith et al. | Jul 2010 | S |
D620122 | Cotton | Jul 2010 | S |
7763000 | Risk, Jr. et al. | Jul 2010 | B2 |
7799004 | Tumey | Sep 2010 | B2 |
7804686 | Parish et al. | Sep 2010 | B2 |
D625018 | Smith et al. | Oct 2010 | S |
D626241 | Sagnip et al. | Oct 2010 | S |
D626242 | Sagnip et al. | Oct 2010 | S |
D626243 | Sagnip et al. | Oct 2010 | S |
D626245 | Sagnip et al. | Oct 2010 | S |
7811269 | Boynton et al. | Oct 2010 | B2 |
D627896 | Matsuo et al. | Nov 2010 | S |
D628300 | Caden | Nov 2010 | S |
7837673 | Vogel | Nov 2010 | B2 |
D630759 | Matsuo et al. | Jan 2011 | S |
7867206 | Lockwood et al. | Jan 2011 | B2 |
7871387 | Tordella et al. | Jan 2011 | B2 |
D631971 | Turtzo et al. | Feb 2011 | S |
D633657 | Oban | Mar 2011 | S |
D634437 | Gramza et al. | Mar 2011 | S |
D634851 | Chiang | Mar 2011 | S |
D635266 | Chiang | Mar 2011 | S |
D635267 | Chiang | Mar 2011 | S |
7896864 | Lockwood et al. | Mar 2011 | B2 |
7896910 | Schirrmacher et al. | Mar 2011 | B2 |
7909861 | Balachandran et al. | Mar 2011 | B2 |
D636497 | Giaccone | Apr 2011 | S |
D638950 | Janzon | May 2011 | S |
D640380 | Tweardy et al. | Jun 2011 | S |
D640381 | Tweardy et al. | Jun 2011 | S |
7959588 | Wolpa | Jun 2011 | B1 |
8007491 | Pinto et al. | Aug 2011 | B2 |
D649648 | Cavalieri et al. | Nov 2011 | S |
8052630 | Kloecker et al. | Nov 2011 | B2 |
8084663 | Watson, Jr. | Dec 2011 | B2 |
8088113 | Scherson et al. | Jan 2012 | B2 |
8100956 | Quisenberry et al. | Jan 2012 | B2 |
8109981 | Gertner et al. | Feb 2012 | B2 |
D655420 | Bowles | Mar 2012 | S |
D655821 | Matsuo | Mar 2012 | S |
8128672 | Quisenberry et al. | Mar 2012 | B2 |
8142486 | Quisenberry et al. | Mar 2012 | B2 |
D657063 | Chiang | Apr 2012 | S |
8157792 | Dolliver et al. | Apr 2012 | B2 |
D660438 | Kennedy et al. | May 2012 | S |
D660439 | Chen et al. | May 2012 | S |
D662212 | Quisenberry | Jun 2012 | S |
D662213 | Quisenberry | Jun 2012 | S |
D662214 | Quisenberry | Jun 2012 | S |
8202262 | Lina et al. | Jun 2012 | B2 |
D663850 | Joseph | Jul 2012 | S |
D664260 | Quisenberry | Jul 2012 | S |
D665088 | Joseph | Aug 2012 | S |
D665470 | Galbraith | Aug 2012 | S |
D666258 | Campbell | Aug 2012 | S |
D666301 | Joseph | Aug 2012 | S |
8240885 | Miller | Aug 2012 | B2 |
8248798 | Parish et al. | Aug 2012 | B2 |
D679023 | Quisenberry | Mar 2013 | S |
8425580 | Quisenberry et al. | Apr 2013 | B2 |
D683042 | Quisenberry | May 2013 | S |
8444581 | Maxon-Maldonado et al. | May 2013 | B1 |
8449483 | Eddy | May 2013 | B2 |
8485995 | Maxon-Maldonado | Jul 2013 | B1 |
8529613 | Radziunas et al. | Sep 2013 | B2 |
8569566 | Blott et al. | Oct 2013 | B2 |
8574278 | Quisenberry | Nov 2013 | B2 |
8632576 | Quisenberry | Jan 2014 | B2 |
8753300 | Deshpande | Jun 2014 | B2 |
8753383 | Parish et al. | Jun 2014 | B2 |
8758419 | Quisenberry et al. | Jun 2014 | B1 |
8772567 | Eckstein et al. | Jul 2014 | B2 |
8778005 | Parish et al. | Jul 2014 | B2 |
8827935 | Maxon-Maldonado | Sep 2014 | B2 |
8834393 | Maxon-Maldonado et al. | Sep 2014 | B2 |
8940034 | Quisenberry | Jan 2015 | B2 |
9101463 | Stormby | Aug 2015 | B2 |
9114055 | Edelman et al. | Aug 2015 | B2 |
9119705 | Parish | Sep 2015 | B2 |
9132057 | Wilford et al. | Sep 2015 | B2 |
9180041 | Parish et al. | Nov 2015 | B2 |
9192539 | Parish et al. | Nov 2015 | B2 |
9669233 | Quisenberry et al. | Jun 2017 | B2 |
20010018604 | Elkins | Aug 2001 | A1 |
20010039439 | Elkins et al. | Nov 2001 | A1 |
20020058976 | Lee | May 2002 | A1 |
20020116041 | Daoud | Aug 2002 | A1 |
20020143373 | Courtnage et al. | Oct 2002 | A1 |
20030050594 | Zamierowski | Mar 2003 | A1 |
20030054046 | Burrell et al. | Mar 2003 | A1 |
20030083610 | McGrath et al. | May 2003 | A1 |
20030089486 | Parish et al. | May 2003 | A1 |
20030089487 | Parish, IV et al. | May 2003 | A1 |
20030125649 | McIntosh | Jul 2003 | A1 |
20030127215 | Parish, IV et al. | Jul 2003 | A1 |
20030135252 | MacHold et al. | Jul 2003 | A1 |
20030139255 | Lina | Jul 2003 | A1 |
20030163183 | Carson | Aug 2003 | A1 |
20030171703 | Grim et al. | Sep 2003 | A1 |
20030176822 | Morgenlander | Sep 2003 | A1 |
20030191437 | Knighton et al. | Oct 2003 | A1 |
20040008483 | Cheon | Jan 2004 | A1 |
20040030281 | Goble et al. | Feb 2004 | A1 |
20040046108 | Spector | Mar 2004 | A1 |
20040054307 | Mason et al. | Mar 2004 | A1 |
20040068309 | Edelman | Apr 2004 | A1 |
20040068310 | Edelman | Apr 2004 | A1 |
20040099407 | Parish, IV et al. | May 2004 | A1 |
20040133135 | Diana | Jul 2004 | A1 |
20040176805 | Whelan et al. | Sep 2004 | A1 |
20040186535 | Knowlton | Sep 2004 | A1 |
20040193218 | Butler | Sep 2004 | A1 |
20040210176 | Diana | Oct 2004 | A1 |
20040221604 | Ota et al. | Nov 2004 | A1 |
20040260231 | Goble et al. | Dec 2004 | A1 |
20050004636 | Noda et al. | Jan 2005 | A1 |
20050006061 | Quisenberry et al. | Jan 2005 | A1 |
20050033390 | McConnell | Feb 2005 | A1 |
20050039887 | Parish, IV et al. | Feb 2005 | A1 |
20050070828 | Hampson et al. | Mar 2005 | A1 |
20050070835 | Joshi | Mar 2005 | A1 |
20050080465 | Zelickson et al. | Apr 2005 | A1 |
20050126578 | Garrison | Jun 2005 | A1 |
20050133214 | Pfahnl | Jun 2005 | A1 |
20050143797 | Parish et al. | Jun 2005 | A1 |
20050177093 | Barry et al. | Aug 2005 | A1 |
20050182364 | Burchman | Aug 2005 | A1 |
20050187500 | Perry et al. | Aug 2005 | A1 |
20050256556 | Schirrmacher et al. | Nov 2005 | A1 |
20050274120 | Quisenberry et al. | Dec 2005 | A1 |
20050284615 | Parish et al. | Dec 2005 | A1 |
20060034053 | Parish et al. | Feb 2006 | A1 |
20060035122 | Weissman et al. | Feb 2006 | A1 |
20060058714 | Rhoades | Mar 2006 | A1 |
20060116620 | Oyaski | Jun 2006 | A1 |
20060167531 | Gertner et al. | Jul 2006 | A1 |
20060217787 | Olson et al. | Sep 2006 | A1 |
20060241549 | Sunnen | Oct 2006 | A1 |
20060253089 | Lin | Nov 2006 | A1 |
20060276845 | George et al. | Dec 2006 | A1 |
20060282028 | Howard et al. | Dec 2006 | A1 |
20070032778 | Heaton et al. | Feb 2007 | A1 |
20070068651 | Gammons et al. | Mar 2007 | A1 |
20070112401 | Balachandran et al. | May 2007 | A1 |
20070118194 | Mason et al. | May 2007 | A1 |
20070129658 | Hampson et al. | Jun 2007 | A1 |
20070233209 | Whitehurst | Oct 2007 | A1 |
20070239232 | Kurtz et al. | Oct 2007 | A1 |
20070260162 | Meyer et al. | Nov 2007 | A1 |
20070282249 | Quisenberry | Dec 2007 | A1 |
20080058911 | Parish et al. | Mar 2008 | A1 |
20080064992 | Stewart et al. | Mar 2008 | A1 |
20080071330 | Quisenberry | Mar 2008 | A1 |
20080082029 | Diana | Apr 2008 | A1 |
20080103397 | Barak | May 2008 | A1 |
20080103422 | Perry et al. | May 2008 | A1 |
20080125775 | Morris | May 2008 | A1 |
20080132816 | Kane et al. | Jun 2008 | A1 |
20080132976 | Kane et al. | Jun 2008 | A1 |
20080249559 | Brown et al. | Oct 2008 | A1 |
20080262399 | Kovelman et al. | Oct 2008 | A1 |
20080319362 | Joseph | Dec 2008 | A1 |
20090069731 | Parish et al. | Mar 2009 | A1 |
20090076475 | Ross et al. | Mar 2009 | A1 |
20090109622 | Parish et al. | Apr 2009 | A1 |
20090149821 | Scherson et al. | Jun 2009 | A1 |
20090237264 | Bobey | Sep 2009 | A1 |
20090254159 | Stormby | Oct 2009 | A1 |
20090254160 | Shawver et al. | Oct 2009 | A1 |
20100010477 | Augustine et al. | Jan 2010 | A1 |
20100030306 | Edelman et al. | Feb 2010 | A1 |
20100081975 | Avitable et al. | Apr 2010 | A1 |
20100121230 | Vogel et al. | May 2010 | A1 |
20100137764 | Eddy | Jun 2010 | A1 |
20100145421 | Tomlinson et al. | Jun 2010 | A1 |
20100150991 | Bernstein | Jun 2010 | A1 |
20100160838 | Krespi | Jun 2010 | A1 |
20100179469 | Hammond et al. | Jul 2010 | A1 |
20100186436 | Stormby | Jul 2010 | A1 |
20100210982 | Balachandran et al. | Aug 2010 | A1 |
20100249679 | Perry et al. | Sep 2010 | A1 |
20100249680 | Davis | Sep 2010 | A1 |
20100305524 | Vess et al. | Dec 2010 | A1 |
20100331797 | Patel et al. | Dec 2010 | A1 |
20110009785 | Meyer et al. | Jan 2011 | A1 |
20110034861 | Schaefer | Feb 2011 | A1 |
20110037002 | Johnson et al. | Feb 2011 | A1 |
20110071447 | Liu et al. | Mar 2011 | A1 |
20110082401 | Iker et al. | Apr 2011 | A1 |
20110087142 | Ravikumar et al. | Apr 2011 | A1 |
20110245788 | Marquez Canada | Oct 2011 | A1 |
20110275983 | Quisenberry et al. | Nov 2011 | A1 |
20110282269 | Quisenberry et al. | Nov 2011 | A1 |
20120041526 | Stormby | Feb 2012 | A1 |
20120130457 | Gammons et al. | May 2012 | A1 |
20120259266 | Quisenberry | Oct 2012 | A1 |
20120289885 | Cottrell et al. | Nov 2012 | A1 |
20130030331 | Quisenberry et al. | Jan 2013 | A1 |
20130030395 | Croizat et al. | Jan 2013 | A1 |
20130103123 | Khan et al. | Apr 2013 | A1 |
20130116612 | Stephan | May 2013 | A1 |
20130191437 | Itoh | Jul 2013 | A1 |
20130216627 | Galbraith et al. | Aug 2013 | A1 |
20130245508 | Maxon-Maldonado | Sep 2013 | A1 |
20130245519 | Edelman et al. | Sep 2013 | A1 |
20130253383 | Maxon-Maldonado | Sep 2013 | A1 |
20130261512 | Maxon-Maldonado et al. | Oct 2013 | A1 |
20130281947 | Quisenberry | Oct 2013 | A1 |
20130331767 | Quisenberry | Dec 2013 | A1 |
20140012169 | Wilford et al. | Jan 2014 | A1 |
20140046410 | Wyatt | Feb 2014 | A1 |
20140052054 | Quisenberry | Feb 2014 | A1 |
20140236271 | Fronda et al. | Aug 2014 | A1 |
20140257175 | Quisenberry | Sep 2014 | A1 |
20140316330 | Fudem et al. | Oct 2014 | A1 |
20140323949 | Quisenberry | Oct 2014 | A1 |
20150133849 | Quisenberry et al. | May 2015 | A1 |
20150290364 | Wall et al. | Oct 2015 | A1 |
20150328042 | Parish et al. | Nov 2015 | A1 |
20160030236 | Parish et al. | Feb 2016 | A1 |
20160067104 | Sarangapani et al. | Mar 2016 | A1 |
20160082238 | Wells et al. | Mar 2016 | A1 |
20160317348 | Banker | Nov 2016 | A1 |
20170119940 | Quisenberry | May 2017 | A1 |
20180369462 | Anderson et al. | Dec 2018 | A1 |
Number | Date | Country |
---|---|---|
670 541 | Jun 1989 | CH |
35 22 127 | Jan 1987 | DE |
0076074 | Apr 1983 | EP |
0 489 326 | Jun 1992 | EP |
0864309 | Sep 1998 | EP |
2373444 | Sep 2002 | GB |
2009504246 | Feb 2009 | JP |
689674 | Oct 1979 | SU |
WO-8204184 | Dec 1982 | WO |
WO-1989009583 | Oct 1989 | WO |
WO-9309727 | May 1993 | WO |
WO-9312708 | Jul 1993 | WO |
WO-1996005873 | Feb 1996 | WO |
WO-9807397 | Feb 1998 | WO |
WO-1998016176 | Apr 1998 | WO |
WO-0040186 | Jul 2000 | WO |
WO-0114012 | Mar 2001 | WO |
WO-0154635 | Aug 2001 | WO |
WO-03047479 | Jun 2003 | WO |
WO-2004103452 | Dec 2004 | WO |
WO-2004105676 | Dec 2004 | WO |
WO-2005046760 | May 2005 | WO |
WO-2007019038 | Feb 2007 | WO |
WO-2008099017 | Aug 2008 | WO |
WO-2010124234 | Oct 2010 | WO |
WO-2012067918 | May 2012 | WO |
Entry |
---|
U.S. Appl. No. 15/227,417, filed Aug. 3, 2016, Overton et al. |
U.S. Appl. No. 15/370,689, Quisenberry. |
U.S. Appl. No. 12/730,060, Parish et al. |
U.S. Appl. No. 12/708,422, Balachandran et al. |
U.S. Appl. No. 12/871,188, Parish et al. |
U.S. Appl. No. 13/107,264, Quisenberry. |
U.S. Appl. No. 12/364,434, Quisenberry. |
U.S. Appl. No. 13/190,564, Quisenberry et al. |
U.S. Appl. No. 29,397,856, Quisenberry. |
U.S. Appl. No. 29/400,194, Quisenberry. |
U.S. Appl. No. 29/400,202, Quisenberry. |
U.S. Appl. No. 29/400,212, Quisenberry. |
U.S. Appl. No. 29/402,115, Quisenberry. |
U.S. Appl. No. 13/796,139, Quisenberry. |
U.S. Appl. No. 13/962,994, Quisenberry. |
U.S. Appl. No. 14/062,428, Quisenberry. |
U.S. Appl. No. 14/197,324, Quisenberry. |
Artikis, T., PCT International Preliminary Report on Patentability dated Jul. 29, 2005, (10 pgs.). |
Tom Lee, T.Y. et al; “Compact Liquid Cooling System for Small, Moveable Electronic Equipment”, IEEE Transactions on Components, Hybrids, and Manufacturing Technology, Oct. 15, 1992, vol. 15, No. 5, pp. 786-793. |
Copenheaver, Blaine R., “International Search Report” for PCT/US2007/022148 dated Apr. 2, 2008, 2 pages. |
Young, Lee W., “International Search Report” for PCT/US07/08807 dated Mar. 3, 2008, (3 pages). |
Mahmoud Karimi Azar Daryany, et al., “Photoinactivation of Escherichia coli and Saccharomyces cerevisiae Suspended in Phosphate-Buffered Saline-A Using 266- and 355-nm Pulsed Ultraviolet Light”, Curr Microbiol, vol. 56, 2008, pp. 423-428. |
J. Li, et al., “Enhanced germicidal effects of pulsed UV-LED irradiation on biofilms”, Journal of . Applied Microbiology, 2010, pp. 1-8. |
Cyro/Temp Therapy Systems; Product News Catalogue; Jobst Institute, Inc., 6 pages (Copyright 1982). |
Quisenberry, Tony, “U.S. Appl. No. 13/359,210”, filed Jan. 26, 2012. |
Quisenberry, Tony, “U.S. Appl. No. 29/424,860”, filed Jun. 15, 2012. |
Quisenberry, Tony, “U.S. Appl. No. 13/456,410”, filed Apr. 26, 2012. |
Copenheaver, Blaine R., “International Search Report” for PCT/US2012/035096 dated Aug. 7, 2012, 3 pages. |
Quisenberry, Tony, “U.S. Appl. No. 13/558,615”, filed Jul. 26, 2012. |
Copenheaver, Blaine R., “International Search Report” prepared for PCT/US2013/030475 dated May 23, 2013, 3 pages. |
Young, Lee W., International Search Report of PCT Application No. PCT/US2014/64805, dated Mar. 13, 2015 (3 pages). |
Hair Science Systems LLC, “Hair Science Systems—01 mobile unit—”, Hair Saver Chemo Cold Cap, www.hairsciencesystems.com, 2 pages. |
“U.S. FDA de novo clearance for the DigniCap® scalp cooling system that reduces hair loss related to chemotherapy for women with breast cancer”, www.sysmex-europe.com/company/news-and -events/press-releases, accessed on Jun. 17, 2016, 3 pages. |
“DigniLife—Prevention of Chermotherapy-Induced Alopecia”, www.sysmex.co.uk/products/oncology/scalp-cooling-system-dignilife, accessed on Jun. 17, 2016, 3 pages. |
Number | Date | Country | |
---|---|---|---|
20150328042 A1 | Nov 2015 | US |
Number | Date | Country | |
---|---|---|---|
60817932 | Jun 2006 | US | |
60791132 | Apr 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11733709 | Apr 2007 | US |
Child | 14812745 | US |